New Vaccine Quality Assessment Assay Developed Using Conformation-Dependent Antibodies Coupled to SE-HPLC
Researchers have developed and validated a stability- and potency-indicating assay protocol for high-throughput quality assessment of vaccines consisting of recombinant virus- “like” particles (VLPs) using conformation-dependent antibodies coupled to size-exclusion high performance liquid chromatography (SE-HPLC).
Photo Credit: Kateryna Kon/Shutterstock.com
Researchers have developed and validated a stability- and potency-indicating assay protocol for high-throughput quality assessment of vaccines consisting of recombinant virus- “like” particles (VLPs) using conformation-dependent antibodies coupled to size-exclusion high performance liquid chromatography (SE-HPLC) (1).
Traditional vaccines utilizing attenuated or inactivated infectious agents often induce unpleasant side effects in their recipients, necessitating research into alternatives, and leading to the development of “subunit vaccines”. These vaccines do not contain live components of the pathogen, but instead contain recombinant protein antigens. Although cheaper to produce and safer to use than conventional vaccines, the recombinant proteins contained within these vaccines can suffer from poor immunogenicity and therefore require extensive testing to ensure effectiveness.
Subunit vaccines have been developed against viruses such as human papillomavirus (HPV), which is the most common cause of viral infections of the genital tract. Strains of HPV can be cancer causing, and have been found to be responsible for approximately 70% of cervical cancer and precancerous cervical lesions (2). The HPV vaccine is quadrivalent containing four types of non-infectious recombinant VLPs, however, currently ELISA remains the only approved in vitro potency testing assay for this vaccine. Despite good reproducibility and specificity, the protocol is time consuming, labour intensive, and sample volume demanding. These limitations raised the need for a more economic and industry friendly approach for quality assessment and batch release of HPV vaccine preparations.
Researchers developed an alternative method for vaccine evaluation using vacuum-immunoaffinity extraction (IAE) columns for sample preparation and IAE coupled to SE-HPLC for the determination of VLPs. The results were compared to the conventional ELISA assay and excellent specificity, sensitivity, and precision were found. The IAEâSEâHPLC assay protocol was demonstrated to be superior to ELISA, extensively reducing analysis time and cost.
References
- M.M. Mostafa et al., J. Chromatogr. B1032, 211–217 (2016).
- WHO fact sheet, Human Papillomavirus (HPV) and Cervical Cancer Fact SheetNo380, 2015 http://www.who.int/mediacentre/factsheets/fs380.
The Next Frontier for Mass Spectrometry: Maximizing Ion Utilization
January 20th 2025In this podcast, Daniel DeBord, CTO of MOBILion Systems, describes a new high resolution mass spectrometry approach that promises to increase speed and sensitivity in omics applications. MOBILion recently introduced the PAMAF mode of operation, which stands for parallel accumulation with mobility aligned fragmentation. It substantially increases the fraction of ions used for mass spectrometry analysis by replacing the functionality of the quadrupole with high resolution ion mobility. Listen to learn more about this exciting new development.
Liquid Chromatography to Analyze Vitamin D Proteins in Psoriasis Patients
January 21st 2025Can a protein involved in delivering Vitamin D to target tissues have an altered serum profile in psoriasis patients with cardiovascular disease? Researchers used liquid chromatography (LC) to help find out.
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
A Guide To Finding the Ideal Syringe and Needle
January 20th 2025Hamilton has produced a series of reference guides to assist science professionals in finding the best-suited products and configurations for their applications. The Syringe and Needle Reference Guide provides detailed information on Hamilton Company’s full portfolio of syringes and needles. Everything from cleaning and preventative maintenance to individual part numbers are available for review. It also includes selection charts to help you choose between syringe terminations like cemented needles and luer tips.
